å¹³æ21å¹´11æ30æ¥ä»ãã§ãæ²ç¸çå½æ°å¥åº·ä¿éºè¨ºçå ±é ¬å¯©æ»å§å¡ä¼ããç§ã®å¤åããã¯ãªããã¯å®ã«ãé£çµ¡äºé ã«ã¤ãã¦ãã¨ããææ¸ãå±ããä¸è¨ã®è¨è¼ãããã¾ããã ãããã¯æ²ç¸çã®å½ä¿ã ãã®åé¡ã§ãä»çã§ãåããããªäºæ ã«ãªã£ã¦ããã®ã§ãããã? æ å ±ããé¡ããããã¾ãã ãã³ã³ãµã¼ã¿ã®æ人ADHDã¸ã®æä¸ã«ã¤ã㦠ãã³ã³ãµã¼ã¿æµé管çå§å¡ä¼ãã§æ¤è¨ä¸ã¨ã®äºã§ãããæ人ADHDã¸ã®æä¸ã¯ä¸»æ²»å»ã®è²¬ä»»ã§èªç±ã«æä¸ããããã¨ã¯ããå¾ã¾ãããããã¾ã§ä¿éºè¨ºçã¨ãã¦ã¯ãä½ããã®éé ããã£ãå ´åãæ£å¼ã«ãè¬å¹ã»è¬ä¾¡ãªã¹ããã«åè¼ãããå ´åã®ã¿ããèªãããã¾ããã®ã§ãæ¤è¨ãã ãããã ãæ²ç¸çã§ãè¤æ°ã®å»å¸«ãæ人ã¸å¦æ¹ãã¦ãããã¨ã¯ç§ãç¥ã£ã¦ãã¾ãããããããå ¨é¨ä¿éºããããªããã¨ã«ãªãã¨ããæé¢ã§ããã¨æãã¾ãã ãå ¨å½ã«ãå¤ãæ人ã¸å¦æ¹ããã¦ããå çæ¹ãå± ãããã¨æãã¾ãã®ã§ãæ å ±ããé¡ããããã¾ã
ããã > ä¸æ¥ã¹ãã¼ã > 大ãªã¼ã° > ç´é¢ããä¸è¦§ > è¨äº ã大ãªã¼ã°ã 注ææ¬ é¥å¤åæ§é害ãå¤ãï¼ï¼ãã¡ã¸ã£ã¼ãªã¼ã¬ã¼ã¯ä¸è¬ã®ï¼å 2009å¹´12æ3æ¥ ç´é¢ãã 大ãªã¼ã¬ã¼ã«æ³¨ææ¬ é¥å¤åæ§é害ï¼ï¼¡ï¼¤ï¼¨ï¼¤ï¼ãæ£ãé¸æãå¢å ãã¦ãããã¨ãåãã£ãã大ãªã¼ã°æ©æ§ï¼ï¼ï¼¬ï¼¢ï¼ã¨é¸æä¼ã¯ï¼æ¥ãæ¨ãªãããä»å£ã®ãã¹ãã·ã¼ãºã³çµäºã¾ã§ç¬ç«æ©é¢ã«ããå®æ½ããããã¼ãã³ã°ï¼ç¦æ¢è¬ç©ä½¿ç¨ï¼æ¤æ»ã®çµæãçºè¡¨ãæ¤æ»åæ°ã¯ï¼ï¼ï¼ï¼åã«ã®ã¼ããçåå¢å¼·å¤ãè奮å¤ã«é½æ§åå¿ã示ããã®ã¯è¨ï¼ï¼ä»¶ï¼ãã¡ã¹ããã¤ã使ç¨ã¯ï¼ä»¶ï¼ã ã£ãã ãã ãä»åã®çºè¡¨ã§è¡æã ã£ãã®ã¯ãå»çç®çã®è¬ç©ä½¿ç¨ã§éåãéããï¼ï¼ï¼ä»¶ã®ãã¡ãï¼ï¼ï¼ä»¶ãADHDã®æ²»çã«å¯¾ãããã®ã ã£ããã¨ãï¼ï¼å¹´ã¯ï¼ï¼ï¼ä»¶ãæ¨å¹´ã¯ï¼ï¼ï¼ä»¶ã¨å¹´ã å¢å å¾åã«ãããAPéä¿¡ã«ããã°ã«ãªãã©ã«ãã¢å·ã®æ°ä¸»å è°å¡ããã¹ããã¤ãã®é½æ§åå¿ãï¼ä»¶ã ãã ã£ãã®ã¯ãããã¥ã¼ã¹
ãµã¼ãã¹çµäºã®ãç¥ãã ãã¤ãYahoo! JAPANã®ãµã¼ãã¹ããå©ç¨ããã ãèª ã«ãããã¨ããããã¾ãã ã客æ§ãã¢ã¯ã»ã¹ããããµã¼ãã¹ã¯æ¬æ¥ã¾ã§ã«ãµã¼ãã¹ãçµäºãããã¾ããã ä»å¾ã¨ãYahoo! JAPANã®ãµã¼ãã¹ããæ顧ãã ããã¾ãããããããããé¡ããããã¾ãã
Influence of methylphenidate treatment on smoking behavior in adolescent girls with attention-deficit/hyperactivity and borderline personality disorders. Clin Neuropharmacol. 2009 Sep-Oct;32(5):239-42. ADHDã¨å¢çåäººæ ¼é害ã®ææ¥æ女å ã®å«ç ã«ãããã¡ãã«ãã§ããã¼ãæ²»çã®å½±é¿ã®è«æã§ããå«ç ã¨ãã³ãã³ä¾åã¯ADHDã®å°å 人å£ã®ä¸ã§åºãæµè¡ã£ã¦ãããä»ADHDã¨å¢çåäººæ ¼é害ï¼ADHD/BPDï¼ãæã¤ææ¥æ女å ã®å«ç ã«ãããã¡ãã«ãã§ããã¼ãï¼MPHï¼æ²»çã®å½±é¿ãè©ä¾¡ããã14-19æ³ã®12人ã®ADHD/BPDã®ææ¥æ女æ§ã¹ã¢ã¼ã«ã¼ããMPHã«ãã8é±éæ²»çãããããADHDã®éç度ã¯AD
ï¼åè¨äºã«ç¶ãï¼ ããã¦ç§ã¯æç´ã®è¿äºã«ãæ人ã¸ã®å¦æ¹ã¯ãããªãã¨æ¸ããã¦ã¯å± ãªãã£ãã¨ç解ãã¦ããã®å¾åä¾ã«ã大人ã«ãå¦æ¹ãã¦ããã ã ãèªåã§åæã«ä½ã£ãä¾åæ§ã¸ã®æ¯æ¢ãã¨ãã¦ãç§ã¯ã2é±éã«3åã¾ã§ã®éå®å¦æ¹ãã¨ããæ¹å¼ãèãã大å¦çãè·æ¥è¨ç·´æ ¡ã®å¦çã§ã³ã³ãµã¼ã¿ã使ããªãã¨ç»æ ¡ãèããå°é£ã«ãªã1ã2ã±ã¼ã¹ãé¤ããæã«6ååç¨åº¦ã®å¦æ¹ããã¦ããããããã§ãã貯ã¾ã£ãå 延ã°ããä¸æ°ã«çä»ãããã«ã¯ããªãæç¨ã§ãå½¹æã®æç¶ãããè¦æãªå®¶äºãéå®å¦æ¹ã®ã³ã³ãµã¼ã¿ãå©ç¨ãã¦ããªãã¦ããæ人ä¾ã¯å¤ãããããããããç§ã¯ç¬¬ä¸ã«ã¯ãè³ã®åãã®éããèªè¦çä»è¦çã«ç解ãããæå³ã§ã³ã³ãµã¼ã¿ãå¦æ¹ãã¦ããããä¸çãéã£ã¦è¦ãããã¨ããæ人å½äºè ãå¤ãã家æãã³ã³ãµã¼ã¿ã§æ¹åããé¨åããé害ã§ãã£ããã¨ç¢ºèªãã¦ç解ãæ·±ã¾ã£ã¦ãããããã¦4æã®è°äºé²ãåç §ããAå»çæ©é¢ã®Bå»å¸«ãæ人ä¾ã«å¦æ¹ããã¨ãã
ADHDã®æ³¨ææ¬ é¥ã«èå¹ããã³ã³ãµã¼ã¿ãæ人ã«å¦æ¹ãã¦è¯ãã®ãã©ããã«ã¤ãã¦ã¯ãæ人çºéé害å½äºè ã«ã¯é常ã«åå®ãªæãã§ãããç¾ã«ç§ã¯18æ³ä»¥ä¸ã¨18æ³ä»¥ä¸ã®ããããã«åæ°åã®å¦æ¹ããã¦ããã ã ãã³ã³ãµã¼ã¿ã¯12æ³ã¾ã§ã®ãå°å ãã¨ãã¦æ¿èªããã¦ããã13æ³ãã18æ³ã¾ã§ãå³å¯ã«ã¯ãé©å¿å¤ãã«ãªãã¨ç§ã¯æãããç§ã®å¦æ¹ã¯ãé©å¿å¤å¦æ¹ãã§ãããã¨ã¯å¦å®ã®ä»æ§ãç¡ãã ã ãã³ã³ãµã¼ã¿ã¯ä¸èº«ã¯ç©è°ãããããããªã¿ãªã³ãã¨åããã®ã§ãããæåã¯è¦ããå¤ã«è¿ããå®éãè¬ç©ä¾åè ã¯ã³ã³ãµã¼ã¿ã®ã«ãã»ã«ãç ãã¦çãã§ä½¿ç¨ãããã¨ãããã¨èãã¦ç§ãé©ããããå¾æ¾å¤ã§ããããããªã¿ãªã³ã¨æ¯ã¹ãã°éè¬çç¶ã¯å¼±ãã¨ã¯ãããããä¾åæ§ã¯ç¢ºãã«ãããã¨ããæå³ã§ã¯æ人ã¸ã®å¦æ¹ã¯è»½ã ã«ãã¹ãã§ãªãã¨ããã®ãå½ç¶ã®è¦è§£ã§ãããããå¹³æ21å¹´3æãç§ã¯æ²ç¸ã§ã®ãã³ã³ãµã¼ã¿æµé管çå§å¡ä¼ãã®ç ä¿®ã«åºæãªã£ããããé«ãé£
大å¦ä¿®å¦è½å試é¨ãåããéå½ã®å¦çãã¡ï¼2008å¹´11æ13æ¥æ®å½±ãæ¬æã¨ã¯é¢ä¿ããã¾ããï¼ã(c)AFP/JUNG YEON-JE ã10æ3æ¥ AFPãå¾¹å¤ã§åå¼·ãããããªããè¨æ¶åãé«ã¾ããè¦ãããã¨ã試é¨ã®æ¬çªã§æãåºãããããªãã¨ãã£ãããããããé ã®è¯ããªãè¬ããç±³å½ã®å¤§å¦çã®éã§äººæ°ã ããã®ç¨®ã®è¬ãæç¨ããå¦çãæ¥å¢ãã¦ãããã¨ãããå°æ¥ã大å¦å´ã¯è©¦é¨åã«ããã¼ãã³ã°æ¤æ»ããå®æ½ããããå¾ãªããªããããããªãââ1æ¥çºè¡ã®å»å¦å«çåé¡ããã¼ãã«ããå°éèªãJournal of Medical Ethicsãã«ããããããã¢ã«ãããã¯ã»ãã¼ãã³ã°ãã®å¯è½æ§ãææããç 究è«æãæ²è¼ãããã è«æãå·çããã®ã¯ã·ããã¼å¤§å¦ï¼University of Sydneyï¼ã®å¿çå¦è ãã³ã¹ã»ã«ããã¯ï¼Vince Cakicï¼æ°ãåæ°ã«ããã¨ãå ¨ç±³ã®å¤§å¦ã対象ã«èª¿æ»ããã¨ãããå ¨å¦çã®4åã®
In some US universities, a quarter of students are reportedly using "smart drugs", and there is anecdotal evidence of increasing use on British campuses. The Academy of Medical Sciences said last year that the use of medicines "off label" is likely to rise. "The expectation that 'off-label' use will increase is borne out by existing advertising of cognition enhancers and smart drugs on the interne
ãããããå¥åº·ãããæèªããã ããããã¨ããããã¾ãã å½ãµã¤ãã¯ã2011å¹´12æ26æ¥ããã¡ã¾ãã¦çµäºãããã¾ãããçæ§ã«ã¯é·ãããæ顧ããã ããèª ã«ãããã¨ããããã¾ããã å¥åº·é¢é£ã®æ å ±ã«ã¤ãã¦ã¯ãæ¥æ¬çµæ¸æ°è é»åçã»ã©ã¤ãã³ã¼ãã¼ã®ããã«ã¹ããã覧ãã ããã
è¦è¦åºå°å¹´äºä»¶èª²ãªã©ã¯è¦ããå¤åç· æ³éåï¼ä½¿ç¨ï¼ã®çãã§ãä½æä¸å®ãç¡è·ã®å°å¥³ï¼ï¼ï¼ï¼ãé®æãããå課ã«ããã¨ãå°å¥³ã¯å®¹çãèªãããè¦éï¼ããããï¼å¤ã¯ï¼ªï¼²è¥¿å «çåé§ åã®ã³ã³ããã§å¤å½äººã®ç·ããè²·ã£ããè¦éå¤ã使ãã¨ãç®ãâã¬ã³éãâã«ãªã£ã¦æé¤ããããæ°åã«ãªã£ããã¨è©±ãã¦ããããé®æ容çã¯ãï¼æï¼ï¼æ¥ãããå¾®éã®è¦éå¤ãå·¦è ã«æ³¨å°ãã¦ä½¿ç¨ããã¨ãã¦ããããåæ¥ååï¼æï¼ï¼åãããæ±äº¬é½å «çåå¸ã®äº¤çªåãæ©ãã¦ããå°å¥³ã«è¦å¯å®ãè·å質åããã¨ãããè¦ç·ãå®ã¾ãããè½ã¡çãã®ãªãæ§åã ã£ããã¨ãªã©ãããç é¢ã§å°¿æ¤æ»ãå®æ½ãè¦éå¤æåãæ¤åºããããããè¬ç©ã®ä¸æ¯çç¶ãè½ã¡çãã®ãå¾ ã£ã¦ï¼æï¼ï¼æ¥ã«é®æããããå課ã«ããã¨ãå°å¥³ã¯å¹³æï¼ï¼å¹´ï¼ï¼æãããã家åºããã¦ãããé®æç´åã¯ä»äººå義ã§åããå¸å ã®ã¦ã¤ã¼ã¯ãªã¼ãã³ã·ã§ã³ã«ä½ãã§ãããå°å¥³ã¯è¦éå¤ã«ã¤ãã¦ã好å¥å¿ã§ãä»å¹´ï¼æããã«åãã¦ä½¿ã£ã
AD/HDã¯ä»äººã¸è¿·æãããããã¨ã¯ãã¾ããªããæ¬äººãå°ãã¨ãããã¨ã¯ãã£ã¦ããåããè¿·æã ã¨ãããã¨ã¯ç¨ãããããªããããããæå³ã§ã¯ãAD/HDã¯åé¡ãªã®ã§ã¯ãªããAD/HDã«ä¸¦åããåæææ¦æ§é害(ODD)ãåé¡ãªã®ã ã¨ããè¦æ¹ã¯ã§ããã ããã åä»ï¼2005 ãææ¥æã®è¡åã®åé¡:Aspergerçå群ã¨ADHDã ãå°å ç§è¨ºçã 68(6) (803) pp.1087ã1092 ADHDã®åé¡ã¯ODDã®çç¶ ADHDã®è¨ºæåºæºãç²¾èªããã¨ããããï¼ADHDã®çç¶ã¯å¨å²ã¸ã®è¿·æã«ã¯ãªãããã©ãï¼å±å®³ã«ã¾ã§ã¯åã°ãªãå ´åãã»ã¨ãã©ã§ããï¼ãã¨ãã°ï¼åæã«ããã¹ã£ã¦ãããããããããªããï¼ããã注æãã¦è¨ãäºãã«ãªã£ã¦ãã¤ãå§å©ã«ãªã訳ã§ã¯ãªãï¼åæã«åãåã£ã¦å±éºã§ãããï¼ã±ã¬ãããã®ã¯æ¬äººã§ãããªã©ï¼ADHDã®ããåã©ãã§ãï¼ä¸å®ã®è·é¢ãåã£ã¦ä¸æã«ä»ãåãã°ï¼æ±ºãã¦å«ã«ãªã訳ã§ã¯
é äºå®¹çè ãã¯ã©ãã§å¥è¡â¦è¡£æãè±ãæ¨ã¦è¸ãçãhttp://www.zakzak.co.jp/gei/200908/g2009080724.html ãæ¬å½ã«ããæè¿ã®æ¼å°¾å¦ã¨é äºæ³åãå·¡ãè¬ç©å ±éã¨ãã®ã´ã¿ã´ã¿ãè¦ã¦ãã¦åãæ°ãããã»ã©ã¦ã³ã¶ãªãã¦ããããããªã«ã¤ã©ã¤ã©ããã®ã¯ãããã£ãã¯ã½ãªãã¥ã¼ã¹ã®æ°¾æ¿«ããä¼è¤è±æã®ãã¸ãã¯ããã·ã¥ã«ã¼ã äºä»¶ã¨ãå士ã®å¤§éº»äºä»¶ä»¥æ¥ç¶ãããã®å½ã®æ°è¡ã®è¬ç©ã«é¢ããç¥èã®ä½ãã¨ãããããçã¾ãã馬鹿ãã®è¡¨ç¾ã¨ããæããªãããã ãã¤ã¾ããåçå´åçã®ããã¡ãã¼ãã¿ã¤ãæ¿çã¨ããææ°è²ææ¿çã¨ããããã被害è ãããªãè¬ç©æ±æãå¾¹åºçã«æ§çã«æããã©ãã§ãããè å¨ãæªãè延ã£ã¦ãããã®ããã«è¦ããããæå£ãããã¦ããããå¾æ´ããæ£ç¾©ã®çµç¹ã麻è¬ã»è¦éå¤ä¹±ç¨é²æ¢ã»ã³ã¿ã¼ãã«è¨å¤§ãªäºç®ãå ¬å¶ã®ã£ã³ãã«ããè£å©äºæ¥è²»ã¨ãã¦æ¯åºããã天ä¸ãããåç®ã ãã®ãã¹ãã«ãªã£
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
å¦çãå®è¡ä¸ã§ã
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}